# Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

> **NCT05671276** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation
- Left Atrial Appendage Occlusion
- Silent Cerebral Embolism

## Interventions

- **DRUG:** aspirin and clopidogrel
- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT05671276
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05671276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05671276, "Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05671276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*